[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354087-105":59,"doc-detail-354087-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","integrated-multi-omics-and-single-cell-analysis-reveals-cdkn2a-mediated-cuproptosis-mechanisms-driving-thyroid-carcinoma-progression","Integrated multi-omics and single-cell analysis reveals CDKN2A-mediated cuproptosis mechanisms driving thyroid carcinoma progression","","Integrated multi-omics and single-cell analyses are used to define copper-dependent cuproptosis gene roles in thyroid carcinoma progression. Bulk and single-cell transcriptomic data stratify tumors into two cuproptosis-related molecular subtypes linked to clinicopathological traits and immune-cell infiltration. A prognostic model based on cuproptosis-related differentially expressed genes predicts patient survival with high accuracy. CDKN2A is consistently upregulated and associates with poor outcome, and single-cell data reveal subtype-dependent cellular distributions in the tumor microenvironment. A GAS5/miR-128-3p/CDKN2A competing endogenous RNA axis is identified and validated, driving proliferation, invasion, and metastasis in vitro and in vivo through regulation of CDKN2A.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-multi-omics-and-single-cell-analysis-reveals-cdkn2a-mediated-cuproptosis-mechanisms-driving-thyroid-carcinoma-progression/354087/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-multi-omics-and-single-cell-analysis-reveals-cdkn2a-mediated-cuproptosis-mechanisms-driving-thyroid-carcinoma-progression/354087.png","ImageObject",300,407,{"name":92,"@type":93},"วิน","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main goal of this study in thyroid carcinoma?","Question",{"text":113,"@type":114},"To characterize cuproptosis-related gene (CRG) expression patterns, define molecular subtypes, evaluate prognostic significance, and assess links with the tumor immune microenvironment using integrated multi-omics data.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were thyroid carcinoma patients classified in the study?",{"text":118,"@type":114},"Tumors were stratified into two CRG-based molecular subtypes using bulk and single-cell transcriptomic data, with consensus clustering identifying k=2 as optimal.",{"name":120,"@type":111,"acceptedAnswer":121},"Which gene and regulatory axis were highlighted as key drivers?",{"text":122,"@type":114},"CDKN2A emerged as the only consistently upregulated CRG correlating with adverse prognosis, and the GAS5/miR-128-3p/CDKN2A competing endogenous RNA axis was identified and experimentally validated.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354087,1790149309,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","npj | systems biology and applications Article  \nPublished in partnership with the Systems Biology Institute  \n[https://doi.org/10.1038/s41540-026-00663-w](https://doi.org/10.1038/s41540-026-00663-w)  \nIntegrated multi-omics and single-cell analysis reveals CDKN2A-mediated cuproptosis mechanisms driving thyroid carcinoma progression  \n Check for updates  \n\n| Jukai Huang1 & Liping Wang2  |  |\n| --- | --- |\n| Cuproptosis is a recently identiﬁed copper-dependent cell death pathway with growing relevance in tumor biology, yet its involvement in thyroid carcinoma (TC) remains poorly understood. In this study, we integrated multi-omics datasets to characterize the functional roles of cuproptosis-related genes (CRGs) in TC progression. Bulk and single-cell transcriptomic datasets from public repositories were analyzed to classify TC into two CRG-based molecular subtypes that showed signiﬁcant associations with clinicopathological features and immune cell inﬁltration. A prognostic model derived from CRGrelated differentially expressed genes exhibited high predictive accuracy for patient survival. CDKN2A emerged as the only consistently upregulated CRG in TC and correlated with adverse prognosis. Single-cell analyses further revealed distinct cellular distributions of CRGs within the tumor microenvironment, with notable enrichment in immune cell populations. In addition, a previously unrecognized competing endogenous RNA network, the GAS5/miR-128-3p/CDKN2A axis, wasidentiﬁed and experimentally validated. Functional assays demonstrated that this regulatory circuit modulates TC cell proliferation, invasion, and metastasis in vitro and in vivo, with GAS5acting for miR- 128-3p to regulate CDKN2A expression. These ﬁndings provide a comprehensive systems-level perspective on cuproptosis-related mechanisms in TC and highlight the therapeutic promise of targeting the cuproptosis pathway and its regulatory networks in thyroid cancer management. |  |\n| Thyroid carcinoma (TC) is one of the most common malignant endocrine tumors, and its incidence continues to rise annually1–4. Although most differentiated TC cases exhibit favorable prognoses, a subset of patients develops recurrence, distant metastasis, or treatment resistance, which signiﬁcantly reduces survival and complicates clinical management3,4. Previous studies have demonstrated that TC exhibits pronounced molecular heterogeneity, which is essential for its classiﬁcation and prognostic evaluation5. However, the expression patterns of cuproptosis-related genes (CRGs) in TC, their prognostic value, their relationship with the tumor microenvironment (TME), and their single-cell distribution remain insufﬁciently deﬁned6,7. Moreover, integrative analyses that combine bulk RNA sequencing and single-cell sequencing to characterize CRGs are still limited. With the rapid development of cloud computing and large genomic data platforms8, multi-omics analysis has emerged as a powerful approach for elucidating tumor molecular mechanisms. Signiﬁcant gaps remain in | understanding the functional roles of CRGs in TC and the regulatory networks that govern their activity.\u003Cbr>Cuproptosis, a form of cell death induced by copper ion carriers, was ﬁrst introduced by Tsvetkov et al.9, 10. The underlying mechanism is closely linked to mitochondrial function, where intracellular copper accumulation promotes oligomerization of mitochondrial lipid-acylated protein aggregates, decreases levels of Fe-S cluster proteins, and generates proteotoxic stress11. Abnormal copper levels have been documented in the serum and tumor tissues ofpatients across several malignancies, such as breast, thyroid, ovarian, and lung cancers12. The combination of copper ionophores, which induce cuproptosis, with small-molecule therapeutics has been proposed asa promising strategy for targeted cancer treatment13–15. Increasing numbers of studies have applied bioinformatic approaches to explore the association between cuproptosis and cancer ","cbCairIv3tD4AF0v","https://ap.wps.com/l/cbCairIv3tD4AF0v","pdf",11740548,16,"English","# Introduction\n## Study objectives and rationale\n# Results\n## Association of CRG subtypes with prognosis, immune infiltration, and metabolic pathways","[{\"question\":\"What was the main goal of this study in thyroid carcinoma?\",\"answer\":\"To characterize cuproptosis-related gene (CRG) expression patterns, define molecular subtypes, evaluate prognostic significance, and assess links with the tumor immune microenvironment using integrated multi-omics data.\"},{\"question\":\"How were thyroid carcinoma patients classified in the study?\",\"answer\":\"Tumors were stratified into two CRG-based molecular subtypes using bulk and single-cell transcriptomic data, with consensus clustering identifying k=2 as optimal.\"},{\"question\":\"Which gene and regulatory axis were highlighted as key drivers?\",\"answer\":\"CDKN2A emerged as the only consistently upregulated CRG correlating with adverse prognosis, and the GAS5/miR-128-3p/CDKN2A competing endogenous RNA axis was identified and experimentally validated.\"}]","Integrated multi-omics and single-cell analysis reveals CDKN2A-mediated cuproptosis mechanisms driving thyroid carcinoma progression | PDF",1790108847,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/421a3ebdcb8081b4d3a33eabbe6efcc2.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/897b63ed4f3352a4d04c0931646dea00.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2b219734596d44b38e73358bb409677.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e406af9ac5de8c87d0db8da87551f4b4.webp",980,1301]